Cavalier Investments’s Repligen RGEN Stock Holding History

Cavalier Investments’s Portfolio RGEN Stock Details RGEN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q4	–	Sell	-5,000	Closed	-$383K	–	146
2019 Q3	$383K	Hold	5,000	–	–	0.17%	96
2019 Q2	$430K	Buy	+5,000	New	+$341K	0.18%	87

Other funds holding RGEN

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return

State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return

CCA

Conestoga Capital Advisors Wayne, Pennsylvania $4.6B AUM 16.08% 1-Year Est. Return

FAM

Fred Alger Management New York $30B AUM 76.99% 1-Year Est. Return

1WCM

12 West Capital Management New York $535M AUM 25.99% 1-Year Est. Return

Federated Hermes Pittsburgh, Pennsylvania $69.6B AUM 42.52% 1-Year Est. Return

Macquarie Group Sydney, NSW 2000, Australia $23.2B AUM 40.19% 1-Year Est. Return

Cavalier Investments's RGEN Position: Q4 2019 in Review

Cavalier Investments sold out of Repligen (RGEN) in Q4 2019, closing a stake of 5,000 shares — an estimated $383K sold.

Cavalier Investments first reported a position in RGEN in Q2 2019 and held it in 2 quarters. The position peaked at $430K in Q2 2019. 306 funds tracked by Wall St. Rank hold RGEN as of Q4 2019.

Cavalier Investments reported no remaining Repligen position as of Q4 2019 after selling out during the quarter.
Cavalier Investments sold 5,000 Repligen shares in Q4 2019, an estimated $383K.
Cavalier Investments first reported a position in Repligen in Q2 2019 and held it in 2 quarters.
Cavalier Investments's Repligen position peaked at $430K in Q2 2019.
306 funds tracked by Wall St. Rank held Repligen as of Q4 2019.

Based on Cavalier Investments's 13F filing for Q4 2019, filed 6 Feb 2020.